We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Response to Letter to the Editor: “Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression”
AI summary Read the abstract
This paper is a response to a letter to the editor concerning the hypothesis that chronic nanoplastic exposure may act as a novel risk amplifier for metabolic dysfunction-associated steatotic liver disease (MASLD) progression, addressing methodological and interpretive points raised by correspondents.
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
More Papers Like This
Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression
AI summary Read the abstract
This study examines the potential for chronic nanoplastic exposure to amplify the progression of metabolic dysfunction-associated steatotic liver disease. The research explores how persistent nanoplastic exposure may act as a novel risk factor that worsens liver disease outcomes. The findings highlight growing concern about the intersection of plastic pollution and metabolic health conditions.
Nanoplastics and MASLD : Unveiling Interorgan Crosstalk and Environmental Modulators
AI summary Read the abstract
This brief editorial discusses the emerging connection between nanoplastic exposure and metabolic-associated steatotic liver disease (MASLD), a condition involving fat buildup in the liver. It highlights how nanoplastics may act as environmental triggers that affect the liver through interactions with the gut and other organs. As MASLD rates rise globally, understanding whether plastic pollution contributes to liver disease is an important emerging area of research.
Response to Letter to the Editor: ‘Nanoplastics and MASLD : Unveiling Interorgan Crosstalk and Environmental Modulators’
AI summary Read the abstract
This is a brief response letter with no substantive scientific content, indicating the authors have nothing to report in reply to a letter about nanoplastics and liver disease.
Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health
AI summary Read the abstract
This review examined emerging evidence linking microplastic exposure to the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). The authors found that microplastics detected in liver tissue can exacerbate hepatic inflammation, lipid accumulation, and oxidative stress through multiple mechanisms, adding a novel environmental risk factor to MASLD pathogenesis.
Chronic Nanoplastic Exposure Promotes the Development and Progression of Metabolic Dysfunction‐Associated Steatotic Liver Disease
AI summary Read the abstract
This study found that chronic exposure to nanoplastics promotes the development and worsening of metabolic dysfunction-associated steatotic liver disease (formerly known as fatty liver disease). Nanoplastics appear to increase vulnerability to liver disease progression. The finding is concerning because fatty liver disease is already widespread, and everyday nanoplastic exposure through food and water could be making it worse.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.